IBI308
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for IBI308, covering 2019-08-14 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC [Phase 2]